HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BAO PHARMA-B

101.100

+2.6002.64%

Volume:356.90K

Turnover:35.31M

Market Cap:32.96B

PE:-83.76

High:102.000

Open:98.500

Low:95.650

Close:98.500

52wk High:105.600

52wk Low:56.000

Shares:325.98M

HK Float Shares:154.00M

Volume Ratio:2.45

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-1.207

ROE:--

ROA:--

PB:33.02

PE(LYR):-83.76

PS:629.63

Loading ...

Overview Company News Filings

BAO PHARMA-B (02659) Full Circulation Explained: How Capital Optimization Empowers Its "Scenario-Driven" Strategy?

Bao Pharmaceuticals Files for Hong Kong-Listed Share Full Circulation

MT Newswires Live

BAO PHARMA-B (02659) Proposes H-Share Full Circulation Plan

Extreme Divergence in HK Biotech IPOs: Bao Pharma Soars 180% While B&K Corp and HanxBio Halve

HK Stock Movement | BAO PHARMA-B (02589) Rises Nearly 5% Against Market Trend, SJ02 Approved for Market Launch and KJ017 NDA Submitted

Stock Track | BAO PHARMA-B Soars 5.08% Intraday on Strong "Three Pillars" Strategy

BAO PHARMA-B (02659): A Sustainable Growth Model Driven by Its "Three Pillars" Strategy

BAO PHARMA-B (02659) Donates HK$1 Million to Support Tai Po Fire Relief and Reconstruction Efforts in Hong Kong

Bao Pharmaceuticals Soars 129% in Hong Kong Trading Debut

MT Newswires Live

Stock Track | BAO PHARMA-B Soars 120.81% in Intraday Trading as Stock Debuts at HK$60.5 vs. Offer Price of HK$26.38

Shares of Shanghai Bao Pharmaceuticals Set to Open at HK$60.5 Each in Hong Kong Debut VS Offer Price HK$26.38 Apiece

THOMSON REUTERS

Bao Pharma Nets HK$921.5 Million from Hong Kong IPO Ahead of Trading Debut

MT Newswires Live

BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under Offering

Frenzy! Dark Pool Trading Soars Over 113%!

HK Movers | Bao Pharma Jumps 105% in Grey Market

Tiger Newspress

IPO Update | BAO PHARMA-B (02659) Closes Subscription with HK$269.21B Margin Financing, Oversubscribed 2,690.8 Times

Beyond ADC and PD-1 Competition: How Bao Pharma-B Charts a "Second Growth Curve" in Biopharma

Baoji Pharma-B (02659) Launches IPO with One Approved Drug, Signaling Revival of HKEX's 18A Biotech Listings

BRIEF-Shanghai Bao Pharmaceuticals Launches Global Offering Of 37.9 Mln H Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02659/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02659","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","market":"HK","secType":"STK","nameCN":"BAO PHARMA-B","latestPrice":101.1,"timestamp":1769501294880,"preClose":98.5,"halted":0,"volume":356900,"delay":0,"changeRate":0.026395939086294357,"floatShares":154000000,"shares":325981465,"eps":-1.207,"marketStatus":"Closed","change":2.6,"latestTime":"01-27 16:08:14","open":98.5,"high":102,"low":95.65,"amount":35305165,"amplitude":0.064467,"askPrice":101.5,"askSize":200,"bidPrice":101,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.279,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769563800000},"marketStatusCode":5,"adr":0,"listingDate":1765296000000,"exchange":"SEHK","adjPreClose":98.5,"openAndCloseTimeList":[[1769477400000,1769486400000],[1769490000000,1769500800000]],"volumeRatio":2.447437,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02659\",,,,,undefined,":{"symbol":"02659","floatShares":154000000,"roa":"--","roe":"--","lyrEps":-1.207,"volumeRatio":2.447437,"shares":325981465,"dividePrice":0,"high":102,"amplitude":0.064467,"preClose":98.5,"low":95.65,"week52Low":56,"pbRate":"33.02","psRate":"629.63","week52High":105.6,"institutionHeld":0,"latestPrice":101.1,"eps":-1.207,"divideRate":0,"volume":356900,"delay":0,"ttmEps":-1.279,"open":98.5,"prevYearClose":77.55,"prevWeekClose":99.3,"prevMonthClose":77.55,"prevQuarterClose":77.55,"fiveDayClose":98,"twentyDayClose":76.2,"sixtyDayClose":26.38},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02659\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02659\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02659\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02659\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02659","date":"2026-01-23","current":-77.013292,"percent":0.1,"low":-80.01007,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"high":-20.527356,"avg":-60.592945,"sd":11.380128,"marketCap":32369959474},"quantilePoints":[{"date":"2025-12-12","current":-53.146224,"twenty":-53.348389,"median":-51.086695,"eighty":-37.627242,"marketCap":22280833132},{"date":"2025-12-19","current":-56.628418,"twenty":-56.115318,"median":-53.146224,"eighty":-50.330094,"marketCap":23796646945},{"date":"2025-12-24","current":-60.667186,"twenty":-57.368285,"median":-54.841733,"eighty":-51.357726,"marketCap":25573245929},{"date":"2026-01-02","current":-53.689307,"twenty":-58.867149,"median":-56.13619,"eighty":-51.993778,"marketCap":22720908110},{"date":"2026-01-09","current":-60.663453,"twenty":-59.744205,"median":-56.240552,"eighty":-53.146224,"marketCap":25736236661},{"date":"2026-01-16","current":-77.814349,"twenty":-61.547088,"median":-57.565784,"eighty":-53.651638,"marketCap":33119716844},{"date":"2026-01-23","current":-76.125836,"twenty":-72.759479,"median":-58.867149,"eighty":-53.689307,"marketCap":32369959474}],"updateTime":1769463647054},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02659\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135953312","title":"BAO PHARMA-B (02659) Full Circulation Explained: How Capital Optimization Empowers Its \"Scenario-Driven\" Strategy?","url":"https://stock-news.laohu8.com/highlight/detail?id=1135953312","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135953312?lang=en_us&edition=fundamental","pubTime":"2026-01-06 09:38","pubTimestamp":1767663537,"startTime":"0","endTime":"0","summary":"In December of last year, following a profound structural reshuffle, Hong Kong's biopharmaceutical sector entered a new window for valuation recovery. As a newly listed 18A company focused on a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02659"],"gpt_icon":0},{"id":"2595799584","title":"Bao Pharmaceuticals Files for Hong Kong-Listed Share Full Circulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2595799584","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595799584?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:52","pubTimestamp":1767091955,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals  submitted filing materials related to the proposed implementation of its Hong Kong-listed share full circulation with the China Securities Regulatory Commission, according to a Tuesday Hong Kong bourse filing.The biotechnology company is looking to convert over 63.1 million unlisted shares into Hong Kong-listed shares.The shares represent around 19.36% of the firm's issued share capital.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659","BK1161"],"gpt_icon":0},{"id":"1182770095","title":"BAO PHARMA-B (02659) Proposes H-Share Full Circulation Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1182770095","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182770095?lang=en_us&edition=fundamental","pubTime":"2025-12-30 17:10","pubTimestamp":1767085831,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) announced that on December 30, 2025, the company submitted filing materials to the China Securities Regulatory Commission for its proposed H-share full circulation plan. The...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","BK1161"],"gpt_icon":0},{"id":"1115768100","title":"Extreme Divergence in HK Biotech IPOs: Bao Pharma Soars 180% While B&K Corp and HanxBio Halve","url":"https://stock-news.laohu8.com/highlight/detail?id=1115768100","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115768100?lang=en_us&edition=fundamental","pubTime":"2025-12-24 13:00","pubTimestamp":1766552455,"startTime":"0","endTime":"0","summary":"December 2025 witnessed a dramatic \"tale of two cities\" in Hong Kong's biotech IPO market. On December 10, BAO PHARMA-B (02659) debuted with a 127% surge, peaking at 170% intraday before closing...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02589","159837","BK1587","02396","BK1173","BK1616","BK1233","BK1535","03378","02659"],"gpt_icon":1},{"id":"1102987607","title":"HK Stock Movement | BAO PHARMA-B (02589) Rises Nearly 5% Against Market Trend, SJ02 Approved for Market Launch and KJ017 NDA Submitted","url":"https://stock-news.laohu8.com/highlight/detail?id=1102987607","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102987607?lang=en_us&edition=fundamental","pubTime":"2025-12-16 11:04","pubTimestamp":1765854287,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02589) gained nearly 5% against the broader market trend, rising 3.79% to HKD 68.45 by the time of writing, with a trading volume of HKD 18.38 million. Recently, BAO PHARMA-B officially...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"13b25d888f050196aeac806a84273b4d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02589","BK1233","BK1587","BK1616","02659"],"gpt_icon":1},{"id":"1139004500","title":"Stock Track | BAO PHARMA-B Soars 5.08% Intraday on Strong \"Three Pillars\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1139004500","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139004500?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:38","pubTimestamp":1765417124,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) saw its stock price surge by 5.08% during the intraday session on Thursday, reflecting strong investor confidence in the company's growth prospects.The rally follows the release...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02659"],"gpt_icon":1},{"id":"1143595545","title":"BAO PHARMA-B (02659): A Sustainable Growth Model Driven by Its \"Three Pillars\" Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=1143595545","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143595545?lang=en_us&edition=fundamental","pubTime":"2025-12-11 09:24","pubTimestamp":1765416274,"startTime":"0","endTime":"0","summary":"In 2025, Hong Kong's 18A biotech sector has witnessed a long-awaited IPO boom. However, unlike previous cycles, investor sentiment has undergone a profound shift—moving away from blind pursuit of...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1109612777","title":"BAO PHARMA-B (02659) Donates HK$1 Million to Support Tai Po Fire Relief and Reconstruction Efforts in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=1109612777","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109612777?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:50","pubTimestamp":1765331415,"startTime":"0","endTime":"0","summary":"On November 26, a severe fire broke out in multiple residential buildings at Hong Fuk Court in Tai Po, Hong Kong, resulting in significant casualties and drawing widespread concern from all sectors...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"2590075376","title":"Bao Pharmaceuticals Soars 129% in Hong Kong Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2590075376","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590075376?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:41","pubTimestamp":1765330916,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals' (HKG:2659) shares opened 129% above its initial public offering price in a stellar Hong Kong debut on Wednesday morning.The biotechnology company opened at HK$60.50 per share, compared with the offer price of HK$26.38.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659"],"gpt_icon":0},{"id":"1145252546","title":"Stock Track | BAO PHARMA-B Soars 120.81% in Intraday Trading as Stock Debuts at HK$60.5 vs. Offer Price of HK$26.38","url":"https://stock-news.laohu8.com/highlight/detail?id=1145252546","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145252546?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:32","pubTimestamp":1765330345,"startTime":"0","endTime":"0","summary":"BAO PHARMA-B (02659) saw its stock price surge by 120.81% during intraday trading on Wednesday, following its debut on the Hong Kong Stock Exchange.The stock opened at HK$60.5 per share,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02659"],"gpt_icon":0},{"id":"2590890376","title":"Shares of Shanghai Bao Pharmaceuticals  Set to Open at HK$60.5 Each in Hong Kong Debut VS Offer Price HK$26.38 Apiece","url":"https://stock-news.laohu8.com/highlight/detail?id=2590890376","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590890376?lang=en_us&edition=fundamental","pubTime":"2025-12-10 09:20","pubTimestamp":1765329618,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nL4N3XG02J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02659"],"gpt_icon":0},{"id":"2590787322","title":"Bao Pharma Nets HK$921.5 Million from Hong Kong IPO Ahead of Trading Debut","url":"https://stock-news.laohu8.com/highlight/detail?id=2590787322","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590787322?lang=en_us&edition=fundamental","pubTime":"2025-12-10 06:20","pubTimestamp":1765318813,"startTime":"0","endTime":"0","summary":"Shanghai Bao Pharmaceuticals  raised HK$921.5 million in net proceeds from its initial public offering in Hong Kong.The final offer price was set at HK$26.38 per share, according to an after-market filing with the Hong Kong Stock Exchange on Tuesday.The biotechnology company offered 37.9 million H-shares in the global offering.The Hong Kong public offer was 3,526.34 times oversubscribed, with a final allocation of 3.79 million shares, or 10% of the total offering.The international offering was 6.59 times subscribed, with a final allocation of 34.1 million shares, or 90% of the total.Cornerstone investors, including AnkeBio Hong Kong, DC Alpha Fund SPC, and Guotai Junan Investments, were allotted a combined 7.6 million shares, representing 20.06% of the global offering.Shanghai Bao Pharmaceuticals is scheduled to debut on the Hong Kong bourse on Wednesday, Dec. 10.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"0f289a0c0f19ee2212a31014a11a9f2a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02659"],"gpt_icon":1},{"id":"2590477953","title":"BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590477953","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590477953?lang=en_us&edition=fundamental","pubTime":"2025-12-09 23:18","pubTimestamp":1765293486,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Bao Pharmaceuticals Announces Final Offer Price HK$26.38 Per H Share Under OfferingDec 9 (Reuters) - Shanghai Bao Pharmaceuticals Co Ltd 2659.HK:FINAL OFFER PRICE HK$26.38 PER H SHARE UNDER OFFERINGFurther company coverage: 2659.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nFWN3XF0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":0},{"id":"1176360621","title":"Frenzy! Dark Pool Trading Soars Over 113%!","url":"https://stock-news.laohu8.com/highlight/detail?id=1176360621","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176360621?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:10","pubTimestamp":1765285838,"startTime":"0","endTime":"0","summary":"The Hong Kong IPO market is heating up.   Today, BAO PHARMA-B (02659), a new Hong Kong-listed stock, surged over 115% in dark pool trading. Based on a lot size of 100 shares, investors could earn HKD...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659","02687"],"gpt_icon":1},{"id":"1194693083","title":"HK Movers | Bao Pharma Jumps 105% in Grey Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1194693083","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194693083?lang=en_us&edition=fundamental","pubTime":"2025-12-09 16:15","pubTimestamp":1765268100,"startTime":"0","endTime":"0","summary":"$Bao Pharma(02659)$ shares jumped 105.3% in in Hong Kong grey market.Founded in 2019, Bao Pharma focuses on four key therapeutic areas, including large-volume subcutaneous drug delivery systems,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"771b03e04e4d4cd469e05db42767a8e9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1165654924","title":"IPO Update | BAO PHARMA-B (02659) Closes Subscription with HK$269.21B Margin Financing, Oversubscribed 2,690.8 Times","url":"https://stock-news.laohu8.com/highlight/detail?id=1165654924","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165654924?lang=en_us&edition=fundamental","pubTime":"2025-12-08 10:47","pubTimestamp":1765162043,"startTime":"0","endTime":"0","summary":"Biotech firm BAO PHARMA-B (02659) concluded its IPO subscription period from December 2 to 5 and is expected to list on December 10. Market data shows that as of last Friday (December 5), the company...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":1},{"id":"1152935994","title":"Beyond ADC and PD-1 Competition: How Bao Pharma-B Charts a \"Second Growth Curve\" in Biopharma","url":"https://stock-news.laohu8.com/highlight/detail?id=1152935994","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152935994?lang=en_us&edition=fundamental","pubTime":"2025-12-05 13:50","pubTimestamp":1764913847,"startTime":"0","endTime":"0","summary":"As China's biopharmaceutical industry navigates an era of both opportunities and challenges, technological innovation and capital influx drive rapid development while intense homogeneous competition...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","02659","BK4023","BK4080","BK4231","LU1169589451.USD","LU1169590202.USD","399441","ADC","161726"],"gpt_icon":0},{"id":"1198813549","title":"Baoji Pharma-B (02659) Launches IPO with One Approved Drug, Signaling Revival of HKEX's 18A Biotech Listings","url":"https://stock-news.laohu8.com/highlight/detail?id=1198813549","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198813549?lang=en_us&edition=fundamental","pubTime":"2025-12-04 16:40","pubTimestamp":1764837638,"startTime":"0","endTime":"0","summary":"The Hong Kong stock market's 18A biotech listing wave has regained momentum, with institutional investors refocusing on these pre-revenue biopharma firms under Chapter 18A of HKEX's listing rules....","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","159992","02659","06978","BK1161"],"gpt_icon":0},{"id":"2588670720","title":"BRIEF-Shanghai Bao Pharmaceuticals Launches Global Offering Of 37.9 Mln H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588670720","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588670720?lang=en_us&edition=fundamental","pubTime":"2025-12-02 06:09","pubTimestamp":1764626957,"startTime":"0","endTime":"0","summary":"BRIEF-Shanghai Bao Pharmaceuticals Launches Global Offering Of 37.9 Mln H SharesDec 2  - Shanghai Bao Pharmaceuticals 2659.HK:GLOBAL OFFERING OF 37.9 MILLION H SHARESOFFER PRICE UNDER GLOBAL OFFERING HK$26.38 PER H SHARENUMBER OF HONG KONG OFFER SHARES OF 3.8 MILLION H SHARES UNDER GLOBAL OFFERINGFurther company coverage: [ ] ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nFWN3X70OD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02659"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}]}}